Abbott (ABT) Tops Q2 EPS by 30c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
July 20, 2022 7:30 AM EDTSales growth of 10.1 percent; organic sales growth of 14.3 percentGAAP diluted EPS growth of 72.7 percent; adjusted diluted EPS growth of 22.2 percentGlobal COVID-19 testing-related sales of $2.3 billion in the second quarterContinues to strengthen portfolio with new product approvals
ABBOTT PARK, Ill., July 20, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2022.
Second-quarter sales of $11.3 billion increased 10.1 percent on a reported basis... More